Legal & General Group PLC Aptinyx Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$2.39 - $3.5 $7,542 - $11,046	-3,156 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.93 - $4.3 $2,880 - $4,226	983 Added 45.24%	3,156 $11,000
Q3 2020 Nov 13, 2020	SELL	$3.05 - $4.99 $2,781 - $4,550	-912 Reduced 29.56%	2,173 $7,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $6,139 - $13,574	3,085 New	3,085 $13,000
Q3 2019 Nov 13, 2019	SELL	$3.0 - $4.08 $6,006 - $8,168	-2,002 Closed	0 $0
Q3 2018 Nov 20, 2018	BUY	$20.21 - $31.85 $40,460 - $63,763	2,002 New	2,002 $58,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.